Search alternatives:
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly shorter (Expand Search)
significantly onto » significantly lower (Expand Search), significantly worse (Expand Search), significantly alter (Expand Search)
significantly teer » significantly better (Expand Search), significantly weaker (Expand Search), significantly lower (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 161 - 180 results of 2,099 for search '(( ((significantly onto) OR (significantly longer)) decrease ) OR ( significantly teer decrease ))', query time: 0.52s Refine Results
  1. 161
    Characterization of the controlled cortical impact model and selection of sub-convulsive dose of PTZ.

    Characterization of the controlled cortical impact model and selection of sub-convulsive dose of PTZ. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 162
    Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus.

    Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 163
    S1 Data -

    S1 Data - by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 164
    Modified Racine score for PTZ-induced seizures. From [28].

    Modified Racine score for PTZ-induced seizures. From [28]. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 165
    Time-dependent effects of CCI on glutamate transporter mRNA.

    Time-dependent effects of CCI on glutamate transporter mRNA. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 166
    Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ.

    Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 167
    Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice.

    Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 168
    Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality.

    Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 169
    Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfarin or DOACs.

    Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfar... by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 170
    Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant.

    Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 171
    Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison.

    Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 172
    Crude incidence rates of stroke and all-cause mortality.

    Crude incidence rates of stroke and all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 173
    Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke.

    Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 174
    Unadjusted cumulative incidence of stroke and all-cause mortality.

    Unadjusted cumulative incidence of stroke and all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 175
    Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects.

    Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke.

    Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 177
    Change in use of Warfarin and DOACs over time, financial incentives to encourage increased detection in the management of AF introduced in 2014.

    Change in use of Warfarin and DOACs over time, financial incentives to encourage increased detection in the management of AF introduced in 2014. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 178
    Particle-Bound Hg(II) is Available for Microbial Uptake as Revealed by a Whole-Cell Biosensor

    Particle-Bound Hg(II) is Available for Microbial Uptake as Revealed by a Whole-Cell Biosensor by Yuping Xiang (11636916)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 179
    Study flow diagram.

    Study flow diagram. by Guangquan An (11473126)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 180
    Summary of PTI and WLI with repeated measurement (mean, 95% CI).

    Summary of PTI and WLI with repeated measurement (mean, 95% CI). by Guangquan An (11473126)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: